Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Journal of Gynecologic Oncology|March 8, 2024
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in JapanHiroko Machida, Koji Matsuo, Takahiro Higashi, et al.
Journal of Gynecologic Oncology|April 1, 2016
Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in JapanYuji Ikeda, Akiko Furusawa, Ryo Kitagawa, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|August 5, 2022
Evaluation of the role of intraoperative frozen section and magnetic resonance imaging in endometrial cancerReina Ooka, Yoshiko Nanki, Wataru Yamagami, et al.
Japanese Journal of Clinical Oncology|October 4, 2017
Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancerTomoko Yoshihama, Hiroyuki Nomura, Naomi Iwasa, et al.
The Journal of Obstetrics and Gynaecology Research|January 28, 2026
Current Status of Fertility-Sparing Treatment for Gynecological Cancers in Japan: A Nationwide SurveyAyumi Shikama, Hiroshi Nishio, Kaoru Okugawa, et al.
Journal of Gynecologic Oncology|November 16, 2021
Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction studyHiroko Machida, Koji Matsuo, Koji Oba, et al.
Japanese Journal of Clinical Oncology|August 11, 2020
A prospective cohort study on the safety and efficacy of bevacizumab combined with chemotherapy in Japanese patients with relapsed ovarian, fallopian tube or primary peritoneal cancerYoshiko Nanki, Hiroyuki Nomura, Naomi Iwasa, et al.
International Journal of Oncology|June 28, 2012
Epimutation and cancer: a new carcinogenic mechanism of Lynch syndrome (Review)Kouji Banno, Iori Kisu, Megumi Yanokura, et al.
International Journal of Clinical Oncology|October 14, 2021
Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patientsNaomi Iwasa-Inoue, Hiroyuki Nomura, Fumio Kataoka, et al.
Anticancer Research|April 13, 2016
Retrospective Analysis on the Feasibility and Efficacy of Docetaxel-Cisplatin Therapy for Recurrent Endometrial CancerTomomi Ninomiya, Wataru Yamagami, Nobuyuki Susumu, et al.
Pageof 16